Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 121 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01GM108648
National Cancer Institute
Grant: R01 CA176166-01A1
National Cancer Institute
Grant: R01 CA225018-01A1
NCI NIH HHS
Grant: R01 CA225018
NCI NIH HHS
Grant: R01 CA247232
NCATS NIH HHS
Grant: UL1 TR001453
NCI NIH HHS
Grant: R01 CA233959
NCI NIH HHS
Grant: R01 CA176166
National Institutes of Health
Grant: 5R01CA225018-02
FANCJ dependent pathways in replication stress
National Institutes of Health
Grant: 1R01CA176166-01A1
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
National Institutes of Health
Grant: 1F32GM013039-01
MOLECULAR ANALYSIS OF THE YEAST HEAT SHOCK TRANSCRIPTION
National Institutes of Health
Grant: 5R01GM108648-02
New Mechanisms of Replication Stress Response
National Institutes of Health
Grant: 1UL1TR001453-01
University of Massachusetts Center for Clinical and Translational Science
National Institutes of Health
Grant: 5R01CA233959-03
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy
University of Connecticut
FWCI
6.27
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals